Filing Flows › Microvast Holdings (MVST) › R&D spending
Microvast Holdings (MVST) R&D spending by quarter
Microvast Holdings' R&D spending was $8.9M in Q2 2026 (second quarter 2026), +0.6% from Q1 2026. Over the last 6 quarters it ranged from $7.7M (Q2 2025) to $10.4M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $8.9M | +0.6% | +15% |
| Q1 2026 | $8.8M | -15% | — |
| Q4 2025 | $10.4M | +34% | +18% |
| Q3 2025 | $7.8M | +0.5% | — |
| Q2 2025 | $7.7M | -12% | — |
| Q4 2024 | $8.8M | — | — |
Q2 2026 at a glance
Microvast Holdings, Q2 2026: revenue $87.3M (-4% year over year), operating margin -2.0%, net loss $12.0M, operating cash flow −$10.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Microvast Holdings' R&D spending?
Microvast Holdings' R&D spending was $8.9M in Q2 2026 (second quarter 2026), +0.6% from Q1 2026.
How has Microvast Holdings' R&D spending changed?
Over the last 6 quarters it ranged from $7.7M (Q2 2025) to $10.4M (Q4 2025).